Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Amplia Therapeutics Ltd.
Dose Escalation Approved in ACCENT Clinical Trial of AMP945
Business
Apr 11 2023
3 min read

Dose Escalation Approved in ACCENT Clinical Trial of AMP945

news images

Amplia Therapeutics Ltd has released a press release.

View Attachment